Development of an innovative in vivo voltammetric technique for measurements of tonic serotonin concentrations in the mammalian brain

Active Project Grant Awarded Last action

Award ID
R01NS129549
Recipient
Awarding agency
Obligated
$5,654,971

Award facts

Completion date 78% complete
Place of performance
Rochester, MN 55905, USA

Award details come from USAspending.gov.

Description

Abstract
We propose to develop and optimize an advanced neurochemical recording technique that would be able to measure relatively rapid physiologically representative second-to-second changes in tonic concentrations of specific neurochemicals, such as serotonin, in the brains of awake behaving animals. Microdialysis, a commonly used in vivo sampling technique, is able to measure changes that occur in tonic levels. However, in practice the sampling timescale is significantly limited to minute-to-minute changes and IT suffers from poor spatial resolution and induces significant tissue damage. Present voltammetry technique can provide tonic measurement capability. However, IT raises concerns for accurate quantification due to the limited approach to eliminate background capacitive current. Furthermore, limited biofouling has been shown, limiting its use for long-term tonic serotonin measurements in awake behaving animals. The proposed electrochemical technique we call n-shaped multiple cyclic square wave voltammetry (n-mcswv) will enable second-to-second measurements of tonic extracellular levels of serotonin with exceptional spatial resolution, sensitivity, specificity, selectivity, and diminished biofouling. This proposal leverages our unique expertise in neuroscience, electrochemistry, software development, and engineering to develop and validate this novel neurochemical recording technology for broad use in basic neuroscience research, clinical brain neuromodulation, and a variety of electrochemical applications. Our initial animal studies will guide and inform the application of our investigational technique for use by the general neuroscience and medical community. Our proposal seeks to (1) establish n-mcswv as a reliable research tool that is capable of identifying and quantifying tonic serotonin extracellular levels in vivo with unsurpassed sensitivity, selectivity, and minimize biofouling, (2) apply fourier transform electrochemical impedance spectroscopy to n-mcswv to monitor the degree of electrode biofouling in vivo, and (3) validate the use of n-mcswv for in vivo, acutely and chronically, selective measurement of tonic serotonin concentrations.

Transactions

Action Obligated Date
Amendment $588,493
Amendment $521,739
Amendment $521,739
Amendment $40,853
Amendment $40,853
Amendment $525,282
Amendment $525,282
Amendment $525,282
Amendment $591,362
Amendment $591,362
Amendment $591,362
Original award $591,362
Show all 12

Subawards

Subrecipient Amount Awarded
Industry University Cooperation Foundation. Hanyang University We propose to develop and optimize an advanced neurochemical recording technique that would be able to measure relatively rapid physiologically representative… $51,030
Industry University Cooperation Foundation. Hanyang University $51,030

Quick answers

Who received award R01NS129549?

R01NS129549 was awarded to Mayo Clinic by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on January 1, 2023.

How much is award R01NS129549 worth?

$5,654,971 has been obligated on R01NS129549.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award